BD Launches AI-Driven Research Cloud 7.0 to Transform Scientific Workflow and Collaboration
- Becton Dickinson & Company launches BD® Research Cloud 7.0, featuring the AI-driven BD Horizon™ Panel Maker for research efficiency.
- The BD Horizon™ Panel Maker generates optimized panel recommendations quickly, improving data reliability and resource usage for researchers.
- BD aims to empower scientific discovery by integrating AI technology, enhancing operational efficiency in immunology and cancer research.
BD Unveils Advanced AI Tool to Enhance Research Efficiency
Becton, Dickinson and Company (BD) announces the global commercial launch of BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, an AI-driven tool aimed at revolutionizing scientific research in immunology and cancer. This innovative platform is designed to streamline the research workflow, promote collaboration among scientists, and manage critical laboratory operations, including instrument health and reagent procurement. The introduction of this cloud-based ecosystem signifies BD's commitment to advancing the capabilities of researchers and improving the quality of scientific results.
The BD Horizon™ Panel Maker stands out with its sophisticated AI algorithms that generate optimized panel recommendations within seconds. Researchers can utilize custom inputs or leverage validated databases to create tailored panels, addressing a common challenge in the field—poorly designed experimental panels that lead to unreliable data and wasted resources. By providing automated recommendations alongside integrated visualization tools such as comparison tables and complexity scores, the Panel Maker enables scientists to efficiently evaluate and select the most appropriate panels for their experiments, ultimately enhancing the reliability of their results.
Steve Conly, worldwide president of BD Biosciences, highlights the significance of these AI capabilities, stating that they are designed to help researchers gain high-quality insights in a fraction of the time, while reducing complexity and potential errors. The BD Horizon™ Panel Maker not only maximizes the efficacy of BD's advanced hardware, such as the BD FACSDiscover™ Cell Analyzer and Cell Sorters, but also reinforces the company’s leadership position in flow cytometry and life sciences research. This release marks a critical step in BD's ongoing mission to empower scientific discovery through innovative technology.
In addition to the BD Horizon™ Panel Maker, the BD® Research Cloud 7.0 offers a comprehensive platform for managing laboratory workflows. This release is timely, as the demand for efficient and reliable research tools continues to grow within the scientific community. With its focus on enhancing research quality and operational efficiency, BD is well-positioned to meet the evolving needs of scientists around the world.
The launch of BD® Research Cloud 7.0 reflects BD's dedication to pushing the boundaries of scientific research. By integrating cutting-edge AI technology into their offerings, BD not only enhances operational efficiency but also contributes to the advancement of critical research areas, including immunology and oncology.
Related Cashu News

HCA Healthcare Raises $3 Billion in Senior Unsecured Notes to Enhance Financial Flexibility
HCA Healthcare successfully completes a public offering of senior unsecured notes totaling US$3.00 billion. This significant move reflects the company’s commitment to bolstering financial flexibility…

IDEXX Laboratories Board Members Show Confidence Through Stock Option Exercises Amid Market Challenges
IDEXX Laboratories (Ticker: IDXX) demonstrates a strong commitment to its future growth as recent insider stock transactions reflect the confidence of its board members. On May 14, several board membe…

Centene Announces Leadership Changes to Strengthen Medicaid and Medicare Operations
Centene Corporation (Ticker: CNC) announces major leadership shifts aimed at boosting its Medicaid and Medicare sectors. These changes could positively impact the company’s strategic direction and ope…

Accuray Partners with University of Wisconsin to Advance Innovative Cancer Therapy Technologies
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…